Skip to main content
. 2025 Jan 21;20(1):6. doi: 10.5334/gh.1390

Table 6.

Study outcomes: between groups comparison (missing imputation analyses).


OUTCOME GROUP N UNADJUSTED ANALYSIS VIA t TEST ADJUSTED ANALYSIS VIA ANCOVA


MEAN SD 95% CI p-VALUE1 MEAN 95% CI p-VALUE2

Office SBP (V2 – V1) Control 49 –2.88 17.24 (–7.83; 2.07) 0.085 –2.457 (–6.858; 1.944) 0.045

Intervention 51 –8.19 13.03 (–11.8; –4.52) –8.959 (–13.775; –4.143)

Office DBP (V2 – V1) Control 49 4.72 6.91 (2.735; 6.70) 0.050 4.869 (2.549; 7.19) 0.019

Intervention 51 1.52 9.03 (–1.01; 4.06) 0.828 (–1.712; 3.367)

Central SBP (V2 – V1) Control 49 0.40 14.33 (–3.71; 4.52) 0.153 1.09 (–2.645; 4.826) 0.042

Intervention 51 –3.43 12.25 (–6.88; 0.01) –4.519 (–8.607; –0.43)

Central DBP (V2 – V1) Control 49 –1.44 10.11 (–4.35; 1.46) 0.791 –1.114 (–3.758; 1.53) 0.736

Intervention 51 –0.95 8.43 (–3.32; 1.42) –1.766 (–4.66; 1.128)

HBPM SBP (V2 – V1) Control 49 –0.04 6.69 (–1.96; 1.88) 0.598 0.273 (–1.794; 2.339) 0.847

Intervention 51 –0.80 7.60 (–2.94; 1.34) –0.019 (–2.28; 2.243)

HBPM DBP (V2 – V1) Control 49 –0.25 5.07 (–1.7; 1.21) 0.828 –0.035 (–1.483; 1.413) 0.634

Intervention 51 –0.03 4.96 (–1.42; 1.37) 0.469 (–1.116; 2.054)

PWV (V2 – V1) Control 49 0.15 0.61 (–0.03; 0.32) 0.146 0.162 (–0.002; 0.327) 0.08

Intervention 51 –0.02 0.53 (–0.17; 0.13) –0.05 (–0.229; 0.13)

FMD (V2 – V1) Control 49 –3.05 8.37 (–5.46; –0.65) <0.001 –2.738 (–5.137; –0.338) <0.001

Intervention 51 4.25 8.18 (1.95; 6.55) 4.587 (1.961; 7.214)

1p-value from unpaired two-samples t-test with equal variance; 2p-value from Ancova models adjusted for gender and BMI (baseline).

SD – standard deviation, V1 – initial visit, V2 – final visit, SBP - systolic blood pressure, DBP - diastolic blood pressure, HBPM – home blood pressure measurement, PWV – pulse wave velocity, FMD – flow mediated dilation.